Navigation Links
Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
Date:3/10/2009

CARMEL, Ind., March 10 /PRNewswire/ -- Christine Lawless, MD, has accepted the position as Medical Director of CME Enterprise, an ACCME-accredited provider of continuing medical education (CME), beginning March 2, 2009. Recognized as one of the world's leading authorities in sports medicine cardiology, Dr. Lawless recently completed her clinical tenure at The Ohio State University Medical Center, where she was Associate Professor of Internal Medicine and Co-Director of Ross Heart Hospital Lipid Clinic.

"Placing Dr. Lawless as Medical Director greatly increases opportunities to engage in cardiovascular and sports medicine, ensuring that the CME Enterprise team will continue its growth as a consummate professional education resource for quality CME," said CME Enterprise owner Deborah Wood.

"I look forward to working with my new colleagues at CME Enterprise as we continue to develop the most relevant curriculum for healthcare professionals," said Dr. Lawless. "The areas of greatest interest and expertise that I bring to CME Enterprise include preventive cardiology, lipids, hypertension, cardiomyopathy, heart disease in athletes, sports cardiology, sudden cardiac arrest and sports medicine."

Dr. Lawless is board certified in internal medicine, cardiovascular disease clinical lipidology¸ and sports medicine. She also is Chair of the US Figure Skating Sports Sciences and Sports Medicine Committee and also Head Team Physician for US Figure Skating. Dr. Lawless serves on the Advisory Board for the National Sudden Cardiac Arrest Association. She holds many other appointments in academic medicine and hospital-based clinical care. "With her expertise and extensive experience in academic and clinical medicine, Dr. Lawless will enable CME Enterprise to establish educational excellence not only in cardiovascular science, but also internal sports medicine for athletes," said CME Enterprise President Bruce J. Bellande, PhD, FACME, CCMEP.

About CME Enterprise

CME Enterprise, an innovative education company, is an ACCME-accredited provider with Exemplary Status in Mission, Needs Assessment, and Effective Measurement of Activities. CME Enterprise develops extensive needs assessments, executes needs-based and competency-based curricula, and impacts physician knowledge and patient outcomes through local, national, and international CME interventions. By engaging in continuous clinical practice performance improvement and healthcare systems quality improvement, CME Enterprise has set itself apart from other medical education companies. For more information about CME Enterprise, visit its Web site at www.cmeenterprise.com.

    Media contact:
    McKenna Goslee
    (317) 846-2879


'/>"/>
SOURCE CME Enterprise
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Former Patent Office Solicitor and Judge Joins Rothwell Figg
8. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
9. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the launch of the Supplyframe Design Lab . Located in Pasadena, Calif., ... the future of how hardware projects are designed, built and brought to market. ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
Breaking Biology Technology:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
Breaking Biology News(10 mins):